A Germline Truncating VEGFB Mutation Causes Severe Familial Hyperlipidemia and Impairs Lipid Metabolism

Clicks: 2
ID: 338179
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #188 of 192 articles by views in qjm : monthly journal of the association of physicians

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 192 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
BACKGROUND: Primary hyperlipidemia is a common metabolic disorder characterized by elevated plasma lipids, leading to fatty liver, acute pancreatitis, and increased cardiovascular risk. Although several causative genes have been identified, substantial genetic heterogeneity remains and the molecular etiology in many patients is unclear. Vascular endothelial growth factor B (VEGFB) regulates tissue fatty acid uptake and lipid metabolism, yet its mutations have not been reported in human hyperlipidemia. AIM: To identify the genetic cause of severe hyperlipidemia in a Chinese family and to functionally characterize the underlying variant. DESIGN: Family-based genetic and functional study. METHODS: We recruited a Chinese family with severe hyperlipidemia. The proband had an 11-year history of hyperlipidemia, complicated by fatty liver, latent glomerulonephritis, and recurrent acute pancreatitis. Whole exome sequencing (WES) was used to determine the genetic etiologies in this family. RESULTS: A novel heterozygous truncation mutation (NM_003377.5: c.361C>T; p.Q121*) of VEGFB gene was detected. Bioinformatics analysis predicted that this mutation leads to truncation of the VEGFB protein, impairing its dimerization and binding to the VEGFR1 receptor. Functional studies revealed reduced VEGFB protein abundance in mutation carriers, and knockdown of VEGFB in HepG2 cells disrupted the AMPK-mediated lipid oxidation pathway, resulting in triglyceride accumulation. CONCLUSIONS: WES was employed to investigate the genetic etiology of a family with hyperlipidemia, leading to the identification of a novel mutation in the VEGFB gene. Our findings established VEGFB as a candidate gene for primary hyperlipidemia, expanded its genetic landscape, and provided a new target for molecular diagnosis.
Reference Key
openalex_W7225114732 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Fang Wang, Xiaoxiao Zhao, Meifang Zhao, Xiaomin Wu, Liangliang Fan, Yuxing Liu
Are you one of these authors? Claim your profile
Journal qjm : monthly journal of the association of physicians
Year 2026
DOI
10.1093/qjmed/hcag310
URL
https://doi.org/10.1093/qjmed/hcag310
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.